Related News
-
Ulcerative Colitis Product…
Friday, March 12, 2010
Ulcerative colitis (UC) is a form of inflammatory bowel disease characterized by a chronic inflammation often with… more...
-
Irritable Bowel Syndrome…
Wednesday, March 10, 2010
Ann Arbor, Mich. -- Patients with irritable bowel syndrome are at no greater risk of having polyps, colon cancer or… more...
-
NICE Recommends Infliximab…
Friday, March 5, 2010
In final draft guidance published today (4 March) NICE has recommended infliximab and adalimumab as treatment options… more...
-
Hit Series Actor Speaks Out…
Thursday, March 4, 2010
New York, NY -- Television celebrity Gregory Itzin, best known for his role as President Charles Logan on FOX's… more...
-
Comprehensive Report on the…
Thursday, March 4, 2010
WASHINGTON -- A groundbreaking new report from the American Autoimmune Related Diseases Association (AARDA), examining… more...
News
-
CheckOrphan NewsFlash, March 2,…
3/02/2010
CheckOrphan NewsFlash for Tuesday, March 2, 2010: breaking news about rare diseases, orphan diseases, orphan drugs, and…
-
CheckOrphan NewsFlash January 15,…
1/15/2010
CheckOrphan NewsFlash for Friday, January 15, 2010: breaking news about rare diseases, orphan diseases, orphan drugs,…
-
CheckOrphan NewsFlash January 11,…
1/11/2010
CheckOrphan NewsFlash for Monday, January 11, 2010: breaking news about rare diseases, orphan diseases, orphan drugs,…
NewsFlash
More News
-
Mesothelioma That Killed Merlin Olsen…
SALT LAKE CITY -- Merlin Olsen passed away Wednesday from mesothelioma, but a doctor has… more...
-
Roche Provides Update on Phase III…
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the topline results of a phase III… more...
-
Ulcerative Colitis Product Granted…
Ulcerative colitis (UC) is a form of inflammatory bowel disease characterized by a… more...
-
Stimuvax Will Become Decision Resources…
WALTHAM, Mass. -- Decision Resources, one of the world's leading research and advisory… more...
-
PSA Test Reduces Prostate Cancer Deaths…
WASHINGTON -- When it comes to the documented 40 percent effectiveness of PSA… more...
Treatment News
St. John's Wort Not Helpful Treatment for Irritable Bowel Syndrome
| More
Tuesday, January 5, 2010
ROCHESTER, Minn. -- A Mayo Clinic research study published in the January issue of the American Journal of Gastroenterology finds that St. John's wort is not an effective treatment for irritable bowel syndrome (IBS).
While antidepressants are frequently used to treat IBS, to date, no study has examined the success of using the herbal supplement St. John's wort in treating IBS.
"Our study investigated if herbal antidepressants such as St. John's wort could benefit irritable bowel disease patients," says Yuri Saito, M.D., M.P.H., gastroenterologist and lead physician scientist on the study. "Several of the chemical neurotransmitters that are in the brain are also in the colon. Therefore, it's been thought that antidepressants may affect sensation in the colon in a similar way to how they affect sensation in the brain. Our goal was to evaluate the usefulness of St John's wort in treating IBS."
In this placebo-controlled trial, 70 participants with IBS were randomized where half the patients received St. John's wort and the other half received a placebo for three months. In all, 86 percent of the participants were women, and the median age was 42 years. After three months of observing symptoms such as stomach pain, diarrhea, constipation and bloating, Mayo researchers found that the placebo group had a better response than the group taking the herbal supplement, St. John's wort.
"Because people tend to struggle with IBS for several years, patients are really looking for inexpensive, over-the-counter treatments such as St. John's wort," says Dr. Saito. "Unfortunately, our study showed that St. John's wort was not successful in helping IBS patients."
St. John's wort is an herbal supplement derived from the St. John's wort plant. It has been shown to be helpful in several medical conditions such as depression as well as other pain syndromes. Research has shown it to be as effective as conventional, prescription anti-depressants in treating mild to moderate depression.
"The challenge with IBS is that there is no cure, no one treatment tends to be wholly effective and some treatments come with significant side effects," explains Dr. Saito. "However, well-designed studies of herbal supplements are important so that physicians and patients can make informed decisions about which supplements to recommend or try. Studies of alternative treatments are generally lacking and patients are forced to use a "trial and error" approach to over-the-counter treatments for their IBS."
IBS is a common disorder that affects the colon and commonly causes cramping, abdominal pain, bloating, gas, diarrhea and constipation. Approximately 58 million people struggle with IBS, mostly women.
***
Each year, Mayo Clinic physicians treat thousands of people with IBS. Read more information on treatment for irritable bowel syndrome at Mayo Clinic.
Mayo Clinic's Division of Gastroenterology and Hepatology has been ranked #1 in the U.S. News & World Report Honor Roll of Top Hospitals since the rankings began 20 years ago.
Other members of the Mayo Clinic research team included Enrique Rey, M.D.; Ann Almazar-Elder; W. Scott Harmsen; Alan Zinsmeister, Ph.D.; G. Richard Locke , M.D.; and Nicholas Talley, M.D., Ph.D.
To request an appointment at Mayo Clinic, please call 480-422-1490 for the Arizona campus, 904-494-6484 for the Florida campus, or 507-216-4573 for the Minnesota campus.
About Mayo Clinic
Mayo Clinic is the first and largest integrated, not-for-profit group practice in the world. Doctors from every medical specialty work together to care for patients, joined by common systems and a philosophy of "the needs of the patient come first." More than 3,700 physicians, scientists and researchers, and 50,100 allied health staff work at Mayo Clinic, which has campuses in Rochester, Minn; Jacksonville, Fla; and Scottsdale/Phoenix, Ariz.; and community-based providers in more than 70 locations in southern Minnesota., western Wisconsin and northeast Iowa. These locations treat more than half a million people each year. To obtain the latest news releases from Mayo Clinic, go to www.mayoclinic.org/news. For information about research and education, visit www.mayo.edu. MayoClinic.com (www.mayoclinic.com) is available as a resource for your health stories
Contact: Amy Tieder newsbureau@mayo.edu 507-284-5005
Source: Mayo Clinic
Log in to comment.